Kappac Pharma Ltd - Due diligence report

A 360° intelligence report on Kappac Pharma Ltd: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1981-08-14 Mumbai, Maharashtra Active Listed Active Non-Compliant
Share
Connect MCP
KP Kappac Pharma Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Kappac Pharma Ltd — 360° Intelligence Report

Generated from MCA filings & public records
54/100
Trust Score
Moderate

Kappac Pharma Ltd is assessed as Moderate with a Trust Score of 54/100. Kappac Pharma Ltd is an active public limited indian non-government company incorporated in 1981, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 09 Oct 2026 from the latest processed filings. Kappac Pharma Ltd snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
54/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Working-capital cover adequate.

Charges position: 7 open (1.68 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Indin Bank7 48.0 cr
Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: BSE, SEBI.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
RAKESH VEKARIYA 01234567 Director 01/04/2018 6 yrs Approved
ZAHURAHMED FAKIR 01234567 Director 01/04/2018 6 yrs Approved
ARUN BHANUBHAI VAGHASIYA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • RAKESH VEKARIYA has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 80
Growth signals & trust indicators
Operating for 45+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (25/100).
7 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence50/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 7 open charge(s) of 1.68 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view51/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
28 Jan 2015
Director ceased
ANAND RAMANLAL TRIVEDI
02 Jan 2015
Director appointed
ZAHURAHMED FAKIR (Director)
Director ceased
VIRAL GUNVANTBHAI KAPADIA
22 Dec 2014
Director appointed
RAKESH VEKARIYA (Additional Director)
Director appointed
ARUN BHANUBHAI VAGHASIYA (Additional Director)
10 Jan 2014
Director ceased
SHANKAR PRASAD BHAGAT
23 Dec 2010
Securities allotted
3000000 Equity Shares Without Differential Rights - 3.00 cr raised
Securities allotted
20000000 Equity Shares Without Differential Rights - 20.00 cr raised
20 Nov 2010
Securities allotted
3000000 Equity Shares Without Differential Rights - 3.00 cr raised
Securities allotted
20000000 Equity Shares Without Differential Rights - 20.00 cr raised
30 Sep 2010
Director ceased
HARLEEN SINGH KATHURIA
30 Mar 2010
Director ceased
GOPALDAS MANTRI
24 Feb 2010
Director ceased
RADHEYSHYAM GANESHNARAYAN SODHANI
10

Key Observations

Auto-generated from the data above
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
MAGIKA ASTERIA SPORTSER LLP AAP-2765 Mumbai, Maharashtra
Parenteral Impex Limited U24239MH2006PLC166419 Mumbai, Maharashtra
Wallem Maritime Training (India) Private Limited U74999MH2004PTC149681 Mumbai, Maharashtra
Smg Studios Private Limited U92100MH1999PTC121722 Mumbai, Maharashtra
Nissi Fabric Private Limited U51311MH2000PTC125934 Mumbai, Maharashtra
CINEMATT PICTURES LLP AAW-6249 Mumbai, Maharashtra
Vansons Datacode Private Limited U74999MH2018PTC305632 Mumbai, Maharashtra
Kurele & Gahoi'S Infrastructure Private Limited U74999MH2007PTC168090 Mumbai, Maharashtra
Hsb Infrastructure Private Limited U45400MH2017PTC293748 Mumbai, Maharashtra
WHITE LIGHT HOSPITALITY LLP AAL-5788 Mumbai, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Kappac Pharma Ltd before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Kappac Pharma Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Kappac Pharma Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 54/100, distress signals and MSME payment-delay disclosures - know whether Kappac Pharma Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Kappac Pharma Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Kappac Pharma Ltd an active company?

Kappac Pharma Ltd has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Kappac Pharma Ltd financially healthy?

Kappac Pharma Ltd has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Kappac Pharma Ltd?

Its overall Trust Score is 54/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Kappac Pharma Ltd?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Kappac Pharma Ltd have loans or charges against its assets?

7 open charge(s) are registered against its assets.

Is Kappac Pharma Ltd up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Kappac Pharma Ltd?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.